Ian Smith Email & Phone Number

Potton, Gb

Birmingham, United Kingdom

Birmingham, United Kingdom

Aston Particle Technologies is developing a radical and highly efficient method of coating substrate particles in the aerosolised state rather than by traditional solid phase processes.

Cambridge Uk

Industry consultant in respiratory product developments, drug delivery device development, and technical business plan developments and evaluation

Oxford, United Kingdom

Raised £14 million with Invesco Asset Management as the lead investor.Glide is a UK based company focused on the development and commercialisation of a simple mechanical system for the safe and convenient injection of solid dose formulations of drugs and vaccines.

Clinton, Ma

Nypro is a world leader in the design and manufacture of high quality drug delivery and medical devices.

Sandwich

Executive Director with staff located in Sandwich and Cambridge, UKGlobal responsibility for inhaled product developments including device and product manufacturing processes Global responsibility for all classes of device development – inhaled, injector, ocular, nasal and othersMember of the company’s Respiratory Medicines Management Team

Melbourn Uk

Drug delivery company focussing on inhaler device development acquired by Pfizer in November 2004Created and developed a novel DPI with performance and patient acceptance beyond the current market leaderCompany valuation of $140 million on the acquisition of Meridica by Pfizer Inc from a total investment of circa $10 million (£5.5 million)

Melbourn Uk

Head of Medical Devices Development Group and Member of the Technology Division BoardStrategic, technology and drug device based consulting to major global pharmaceutical (Novartis, Schering AG, Pfizer Inc) and biotechnology companies (Alkermes, SkyePharma, Weston Medical)PA Consulting Group Lead for a Joint Venture with SkyePharma for MDI device programmeTechnical due diligence for several company and technology acquisitions including LSE listings

Nottingham Uk

Rationalised R&D from 12 to 4 programmes with an increase in staff and clear focus on value-adding developmentsChanged company culture to project a professional approach to R&D and its commercial exploitationEstablished contemporary R&D systems to provided sound basis for subsequent company acquisition

Ware Uk

Lead a team of circa 100 scientists and engineers responsible for inhaled product and device based developmentsLeader of company-wide drug product development project teams Developed current market leading DPI device (Diskus) and the drug products, Imigran intranasal and auto-injector products, paediatric inhaled drug delivery spacer, and their associated manufacturing processes Member of the company’s Respiratory Product Development Committee Member of a United Nations Committee charged with the global phase out of CFCs from aerosol products (1989 – 1994)

Port Sunlight, Wirral Uk

Numerous research roles including; detergents for emerging markets, non-aggressive hand and body soaps, and enhanced technology transfer processes and information science / technology evaluation

Liverpool Uk

Basic research in the field of cross-linked hydrophilic polymer matrices as potential vehicles for de-salination

Phd, Chemistry

Activities and Societies: Founder and Treasurer of the University Post Graduate Association Research in the synthesis of monomers.

Bsc, Chemistry

Organic and physical chemistry